Matches in Wikidata for { <http://www.wikidata.org/entity/Q73076808> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q73076808 description "articolo scientifico (pubblicato il 1997)" @default.
- Q73076808 description "artikull shkencor i botuar më 01 janar 1997" @default.
- Q73076808 description "artículu científicu espublizáu en xineru de 1997" @default.
- Q73076808 description "im Jahr 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73076808 description "scientific article published on 01 January 1997" @default.
- Q73076808 description "wetenschappelijk artikel" @default.
- Q73076808 description "наукова стаття, опублікована в січні 1997" @default.
- Q73076808 name "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 name "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 name "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 type Item @default.
- Q73076808 label "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 label "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 label "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 prefLabel "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 prefLabel "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 prefLabel "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 P1433 Q73076808-24602156-2158-40AF-9F51-77590C5DBF1B @default.
- Q73076808 P1476 Q73076808-D7418094-7A79-49A9-83BB-BCA084D22841 @default.
- Q73076808 P2093 Q73076808-20FF4BF7-DEDE-4E33-A438-8E5576994F0F @default.
- Q73076808 P2093 Q73076808-238B7688-4144-4B1B-90E1-0A5159A1EA33 @default.
- Q73076808 P2093 Q73076808-39C70DEB-C81F-4C54-8ADE-B6A0F7F28CD1 @default.
- Q73076808 P2093 Q73076808-7C7E3C7B-9EA5-4D85-BDEB-4DB710433B49 @default.
- Q73076808 P2093 Q73076808-9E7723B0-1F09-4069-A390-249980595394 @default.
- Q73076808 P2093 Q73076808-9F59F28B-F2A0-4590-A56A-5961376B2D5C @default.
- Q73076808 P2093 Q73076808-EC7D40EB-037E-4589-B268-159E6F4C738B @default.
- Q73076808 P2860 Q73076808-6D9C30E1-79FB-4457-B7E9-EA4FBE49EE4F @default.
- Q73076808 P2860 Q73076808-795EED2A-9CF5-4474-B5F8-99CF399DE159 @default.
- Q73076808 P2860 Q73076808-7FD4BC45-4E19-4A33-8A4F-071E2A71E03D @default.
- Q73076808 P2860 Q73076808-87AC1B90-76B3-4B74-84E1-72E00C7AA500 @default.
- Q73076808 P2860 Q73076808-A89A1CF9-9547-4A5A-90B7-C6E6A5850B24 @default.
- Q73076808 P2860 Q73076808-AD6515D7-4BE9-4ADF-BB14-6E9A46D41596 @default.
- Q73076808 P2860 Q73076808-D82E41F5-3862-4200-B1AC-355F53E66883 @default.
- Q73076808 P2860 Q73076808-F6B72944-30C1-478E-9BD8-D02DAF47908D @default.
- Q73076808 P2860 Q73076808-FF5738EF-591D-4018-ABE1-5592E050751B @default.
- Q73076808 P304 Q73076808-E7ACD5C3-BDFE-4324-9EBF-C43977F9CF2C @default.
- Q73076808 P31 Q73076808-B85A3D0B-A86F-4DA8-B026-CC24EC846CED @default.
- Q73076808 P356 Q73076808-B786BE55-04E4-4B6A-AADC-11393415CF39 @default.
- Q73076808 P433 Q73076808-75AEADF1-7253-40DE-B00D-2E49EFE3E54D @default.
- Q73076808 P478 Q73076808-4595202B-3DB2-4B84-A2CC-2B271D1E35CA @default.
- Q73076808 P577 Q73076808-5A1DA510-CB9D-46F2-A88E-5D7CECC7000F @default.
- Q73076808 P698 Q73076808-86B3AB5D-25BB-4851-969D-77F607074CC3 @default.
- Q73076808 P356 S0929-7855(96)00551-2 @default.
- Q73076808 P698 9034961 @default.
- Q73076808 P1433 Q27714038 @default.
- Q73076808 P1476 "Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3',4',5'-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines" @default.
- Q73076808 P2093 "Blavet N" @default.
- Q73076808 P2093 "Dive G" @default.
- Q73076808 P2093 "Godfroid JJ" @default.
- Q73076808 P2093 "Heymans F" @default.
- Q73076808 P2093 "Lamouri A" @default.
- Q73076808 P2093 "Tavet F" @default.
- Q73076808 P2093 "Touboul E" @default.
- Q73076808 P2860 Q33453907 @default.
- Q73076808 P2860 Q36471365 @default.
- Q73076808 P2860 Q39493359 @default.
- Q73076808 P2860 Q53006300 @default.
- Q73076808 P2860 Q56658601 @default.
- Q73076808 P2860 Q56658602 @default.
- Q73076808 P2860 Q67568391 @default.
- Q73076808 P2860 Q68281346 @default.
- Q73076808 P2860 Q70672516 @default.
- Q73076808 P304 "145-159" @default.
- Q73076808 P31 Q13442814 @default.
- Q73076808 P356 "10.1016/S0929-7855(96)00551-2" @default.
- Q73076808 P433 "2" @default.
- Q73076808 P478 "15" @default.
- Q73076808 P577 "1997-01-01T00:00:00Z" @default.
- Q73076808 P698 "9034961" @default.